A new draft proposal from Andrei Constantinescu and Lioba Heimbach introduces a feature for Monad accounts and smart contracts to schedule transactions for future blockchain blocks. This change would shift recurring on-chain tasks from relying on external keeper software to being handled directly by the protocol, improving reliability and automation. Scheduled transactions would reserve up to 10% of a block's gas capacity and require payment of gas and storage fees upfront, with the transaction value held in escrow until execution. The proposal is still in draft form with no finalized specification or launch date, but it could enable use cases like recurring payments and automated staking rewards in the future.
The Monad draft proposal for protocol-level scheduling of future contract calls is presented here with market context from Pluang's platform. For readers following the broader cryptocurrency market, here is Pluang's snapshot as of Oct 23, 2026 15:51 WIB: out of 50 major cryptocurrencies, 37 rose and 12 fell today. Notable movers include DOT (Polkadot) with a price of Rp21.481 and a 1-day change of +7.72%, ATOM (Cosmos) at Rp32.682 with +6.16%, and COTI at Rp207 with +4.99%. Pluang order activity shows DOT buyers dominate at 89%, while ATOM sellers lead at 90%.
Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...
Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...
Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...
ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...
eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...
